The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Baseline albumin (b-alb) as a potential predictive biomarker for the efficacy of bevacizumab (B) therapy (tx) in patients (pts) with advanced pancreas cancer (APCA): A comparative analysis.
Ludmila Katherine Martin
No relevant relationships to disclose
Susan Michelle Geyer
No relevant relationships to disclose
Anissa Bingman
No relevant relationships to disclose
Mark M. Zalupski
No relevant relationships to disclose
Tanios S. Bekaii-Saab
Consultant or Advisory Role - Roche/Genentech
Research Funding - Roche/Genentech